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Summary 
In this world everywhere, people are affected by diabetes millitus a disease which affects people of 
all ages. A report by the World Health organisation (WHO) shows that 180 million people are affected 
by diabetes mellitus, and this rate will increase upto 360 million people in 2030. The pancreas in the 
human body responsible formaintaining normoglycemia controls the range within 70-120 mg/dl. Beta 
cells produce the insulin in the pancreas when the blood glucose level is high.  Insulin is a hormone 
that allows glucose to enter into the cells of the human body for providing energy. The conditon, Type 
1 Diabetes Mellitus (T1DM) occurs because of the damage of pancreatic beta cells by the body's 
immune system. Hence, manually controlled insulin therapy is suggested by the physician where three 
or four times the blood glucose measurements to be taken by finger picking. Then, subcutaneous 
insulin injection is given based on the daily activities. The automatic blood glucose control is 
challenged by the disturbance of meal intake and internal system changes. 
To avoid the manually injecting insulin and to limit the significant changes in blood glucose 
concentration, an artificial pancreas (using Closed Loop Approach) is developed. The components of 
the artificial pancreas are glucose monitor, insulin pump, and control algorithm. This controlled 
framework is called Automatic Blood Glucose- Insulin (ABGI) regulatory system. 
This thesis proposesthree control strategies for closed loop artificial pancreas and has used three 
diabetic patient models for simulation that is designed to reduce the risks of hyperglycemia. 
The proposed control algorithm is implemented for the Bergmann Minimal Model (BMM) as the 
diabetic patient model. The control algorithm is proposed to develop a closed loop artificial pancreas. 
The conventional Proportional and Derivative (PD) controller and Internal Model control (IMC) are 
designed for the BMM model. Then, the PD and IMC control problem is optimized based on control 
problem to improve the performance of controller. To get optimal controller for the bergmaan 
minimal model (pso) particle swarm optimization algorithm is used, which should minimize the 
Integral Square Error (ISE).This research focus on the development of control algorithm using PSO 
based PD and PSO-IMC. The control problems are studied explicitly and the results show the 
improved performance of the proposed system.  
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Santrauka 
Kiekvienais metais šiame pasaulyje žmonės patiria diabetą. Tai yra liga, paveikianti visų amžiaus 
grupių žmones. Pasaulinės sveikatos organizacijos (PSO) ataskaita rodo, kad diabetu serga 180 
milijonų žmonių, o šis skaičius iki 2030 m. padidės iki 360 milijonų žmonių. Kasa žmogaus kūne, 
atsakinga už gliukozės lygio palaikymą, 70-120 mg / dl. ribose. Beta ląstelės gamina insuliną kasoje, 
kai gliukozės koncentracija kraujyje yra didelė. Insulinas yra hormonas, leidžiantis gliukozei patenkti 
į žmogaus kūno ląsteles ir tiekti energiją. 1-o tipo cukrinis diabetas (T1DM) atsiranda dėl kasos beta 
ląstelių pažeidimų, kurią sukelia organizmo imuninė sistema. Taigi, gydytojo siūloma rankiniu būdu 
kontroliuojama insulino terapija, kurios metu trijų ar keturių kartų kraujo gliukozės matavimai 
atliekami rinkimo būdu. Tada poodinio insulino injekcija skiriama atsižvelgiant į kasdienes veiklas. 
Automatinio gliukozės kiekio kraujyje kontrolė yra susijusi su maisto vartojimo ir vidinių sistemos 
pokyčių sutrikimu. Siekiant išvengti rankiniu būdu švirkščiamo insulino ir riboti reikšmingus 
gliukozės koncentracijos kraujyje pokyčius, sukurta dirbtinė kasa (naudojant uždarojo ciklo metodą). 
Dirbtinės kasos komponentai yra gliukozės monitorius, insulino pompa ir valdymo algoritmas. Ši 
kontroliuojama sistema vadinama automatine gliukozės-insulino (ABGI) reguliavimo sistema. 
Siekiant išvengti rankiniu būdu švirkščiamo insulino ir riboti reikšmingus gliukozės koncentracijos 
kraujyje pokyčius, sukurta dirbtinė kasa (naudojant uždarojo ciklo metodą). Dirbtinės kasos 
komponentai yra gliukozės monitorius, insulino pompa ir valdymo algoritmas. Ši kontroliuojama 
sistema vadinama automatine gliukozės-insulino (ABGI) reguliavimo sistema. Šiame baigiamajame 
darbe siūlomos trys uždaro komtūro dirbtinės kasos valdymo strategijos ir panaudoti trys diabetu 
sergančių ligonių modeliai, skirti sumažinti hiperglikemijos riziką. Siūlomame valdymo algoritme 
yra taikomas Bergmann Minimal Model (BMM) kaip diabetikos paciento modelis. Siūlomas valdymo 
algoritmas skirtas sukurti uždaro kontūro dirbtinę kasą. PD valdiklis ir vidinio modelio valdymas 
(IMC) yra sukurti BMM modeliui. Tada PD ir IMC valdymo problema optimizuojama remiantis 
valdymo problema, siekiant pagerinti valdiklio efektyvumą. Optimizuoto BMM parametro valdiklio 
parametrui naudojamas algoritmas " The Particle Swarm Optimization " (PSO), turėtų sumažinti 
kvadratinę paklaidą (ISE). Šiame tyrime daugiausia dėmesio skiriama valdymo algoritmo kūrimui, 
naudojant PSO grįstą PD ir PSO-IMC. Valdymo uždaviniai išsamiai tiriami, o rezultatai rodo geresnį 
siūlomos sistemos funkciškumą. 
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Introduction 
In this world, people are facing many kinds of disease. According today census 131.4 million births 
per year, 55.3 million death per year 360,000 births per days, 151,600 people die daily. Each person 
dies for different reason like accident, suicide, disaster etc. but mainly they die in different form 
disease even though our medical is improved people are dying its natural calamity that no one can 
stop it [1] 
According today diabetes is the main disease people are facing. Diabetes is caused due to pancreas 
fail to produce insulin or human body not responding insulin secret by pancreas. 
Diabetes mellitus is wide spread disease. In 2011 nearly 346 million people have this problem source 
from world health organization (WHO). In 2030, it will expected to increase up to 552 million 
according to international diabetic based. china, japan, India have more number diabetic patient and 
it rank top three countries [1]. 
This disease is classified into type1 and type 2 .Patients with these types of diabetes require insulin 
for maintaining the blood glucose level . Although there are varieties of injection regimens used in 
insulin , The acceptable glucose reading which are accquired by the usage of single and multiple dose 
does‘nt  reach the expected level. 
These diabetic patient need to control glucose level manually  using insulin on a regular basis. They 
need to measure their glucose level by test strip according to which insulin can be injected  through 
insulin pen or pump .In order to  avoid regular dose of insulin  , and to reduce high variation in glucose  
concentration, the basic solution can be determined by simulating  the insulin dose  based on 
continuous glucose measurements using control algorithm, as it can be obtained by sensor technology 
rather than  manual input. These appropriate insulin injections can be supported by mathematical 
patient model and then appropriate amount of insulin dose are examined by a  controller which 
stimulates the delivery of insulin to the patients continuously 
The Research  study of  Diabetes Control   shows  that frequent  control  in blood glucose level for 
diabetes patients shows minimal  variations in  glucose concentration . Decreasing rate of secondary 
diabetic disorders improve their heath. 
Therefore  automated development insulin pump of a  closed-loop system  have advantage control 
glucose level for both  diabetic patients and the healthcare system [1]. 
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Aim 
The main aim of the thesis is the development of the control system and also to improve its 
performance to control the glucose level devoted for diabetes Type 1 patient. 
Main task of this research work  
• To develop a closed loop system with ZN based PD controller for diabetic patients 
• To design a IMC controller for blood glucose level system. 
• To  design a PD controller and IMC using particle swarm optimization technique.  
• Finally to compare the results of PD controller, IMC, IMC based PID, PSO-PD & PSO-IMC. 
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1. Literature survey 
In this present scenario, human beign are facing lot many health issues all over the world wide and 
now the survey is been recorded by world health organization (WHO) that diabetes mellitus is a 
disease which is been affected by 180 million people all over the world. In future 2030, this disease 
will be affected by double the time of 360 million people and it is been guaranteed by them. In order 
to avoid this, we should maintain normoglycemia which is in the range of  (70-120 mg/dl) by 
controlling blood glucose level which is been handled by pancreas . While, the glucose level goes 
high, insulin is secreted by the beta cells of pancreas. This insulin is a peptide hormone which gives 
energy to the human body when the glucose enters the human body. It also develops the intake of 
glucose into the human cells and glucose is been stored in liver as glycogen. While, the blood glucose 
level goes low the pancreases secretes glucagon. This glucagon has the negative effect as it is shown 
in the figure. 1.1. Also there exist different types of Diabetes mellitus, where Type 1 diabetes mellitus 
T1DM occurs due to the damage of pancreatic cells caused by the immune system [2] [3]. 
Later case studies by diabetes control is been generated by the research group, which shows there 
exist the slight variation of glucose concentration when the blood glucose level of the patient is 
frequently controlled. On the other hand when there is a decrease in secondary diabetic disorder, it 
gradually increases patient’s life and thereby reduces the cost of treatment.  Also it is found that, 
global health care budget to take care of complications related to diabetes is been increased 
sufficiently within upcoming years, for instance it is approximately from 375 B$ to nearly 490 B$. 
The history related to the group of people with diabetes in countries like  Asia, US, Europe, Africa, 
Brazil for the year 2010 and 2030 is graphically shown in the figure 2.2. T1DM (Type 1 Diabetes 
Mellitus) earlier known as insulin independent diabetes. The number people who is been affected by 
T1DM is found to around 30,000 in Denmark. Since these many people is been affected it is called 
as an autoimmune disease. So the people use exogenous insulin to survive their lives. While deciding 
on insulin dosage we need to too careful. Too little intake of insulin may lead to problems like 
blindness, problem in kidney, nerve related damage, etc.. or conversely over dosage of insulin may 
also leads to low sugar level which may even lead to death [2] [3]. 
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Figure 1.1.  Blood glucose regulation in healthy people [3]. 
 
 
Figure 1.2 Estimation of the number of people with diabetes in the    usa, europe, india, china, brazil and 
africa in 2010 and 2030 (boiroux et al 2012) [4]. 
 
 
 
 
 
 
 
14 
1.1 Artificial pancreas 
 
 
Figure 1.3.  Design of an artificial pancreas (boiroux et al 2012) [5]. 
 
In order to keep track of glycemic control, it has been observed as the ideal resolution of developing 
an artificial pancreas. The artificial pancreas is a technology that automatically controls the  glucose 
level  of blood for the patients. The controlled  glucose level of blood should be within the desired 
range and limits in order to minimize or eliminate the need for patient help. 
For the fully developed  man-made pancreas, it has been said that control of blood glucose after a 
meal is one of the important challenger. The important reason for the increase of glucose into the 
blood stream is caused by meals. The CGM sensor detects when there is increase in glucose level has 
occurred only after the controller reacts to it.  Insulin overloading is caused due to elevated glucose 
level, which results in postprandial hypoglycemia. 
For almost 5decades the artificial pancreas has been subject of interest. Intravenous glucose 
measurements and intravenous insulin and glucose injection uses bio-stator which are the early 
versions of AP. The blood glucose cannot be controlled in everyday life. Fully automated artificial 
pancreas has increased the potential due to the  better improvements in CS11 pump technologies, 
insulin analogs and CGMs. 
The three compartment minimal model was proposed by Bergman et al is used to test the 
disappearance of glucose in the blood and  sensitivity of insulin which occurs during an intravenous 
glucose tolerance test. Overall there are three sections that explain about glucose insulin dynamics 
model. Plasma glucose level describes the first section. The action of insulin represents second section 
and at last the insulin concentration illustrates the third section. It is common among people with 
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type1 diabetes. In literature it has been said that it is most popularly utilized model and dynamic 
response of a diabetic patient’s blood glucose is analyzed. Original minimal model have undergone 
some modifications that includes the various physiological effects.  
To separate the effect of glucose generation utilization, cobelli et al in 1986 proposed a revised version 
of minimal model. Another publication was done by cobelli et al in the year 1999, which illustrates 
the over evaluation of glucose effectiveness and underestimation of insulin, sensibly. The original 
model is been added to the second non accessible glucose section. Then the original minimal model 
is continued by hovorka et al by adding three glucose and insulin sub – section to capture absorption, 
distribution and dynamics. 
Since 1970, the lengthy research process has been done for the artificial endocrine pancreas. The 
control approaches planned for the intravenous glucose sampling and intravenous insulin infusion. 
Initially, the work is been done by albisser et al and Pfeiffer et al, designed and developed the glucose 
controlled insulin infusion system (GCIIS) which leads to the management of bio stator. In respect to 
this algorithm, albisser et al, changes the rate of glucose which is been linked to it by insulin mixture. 
The advanced algorithm followed by the great scientist fischer et al, fischer and tio, ollerton, shichiri 
et al is been developed accordingly. Parker et l made an excellent review of algorithms based on 
intravenous insulin delivery [5]. 
In recent times, medical sciences place more emphasis on prevention and offers only general 
treatment for illness. Survey says that, in order to improve the diabetes treatment, biomedical 
engineering designs new instruments for the instance insulin pump. This is a medical device which is 
being used for the treatment of diabetes mellitus. This device has an application in both the type of 
diabetes, but one thing we need to monitor is about the designing of suitable controller for insulin 
pump.  
The steps for the design of an appropriate controller are as follows. 
1. The taken dosage of insulin should be minimized by the controller by chase et al. 
2. The blood glucose level should be lowered by the controller in the shortest period of time within 
the allowed desired range, that is from 70 - 120 mg/dl before meals and below 180mg/dl after meals 
by koacs et al, li &hu, beyki et al. 
3. It is to be known that the controller should be in order to perform the robust action, as it is to be 
used on all diabetic patients, Such parameter uncertainties that exist in diabetic model by acikgoz, 
diwekar, kovacs et al [5]. 
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For closed-loop artificial pancreas system, the insulin therapy should believe the fact that 
hyperglycemia is not a naturally occurring episode in T1DM. 
In general, these algorithms becoming popular among many control engineers, where they involve in 
the process of optimal tuning of PID, MPC, Fuzzy controllers, etc.., The reason is that these are the 
parameters which gives accurate evaluation in the process and thereby illustrates the engineers to 
work on it. 
A fuzzy PI controller for glucose concentration using genetic algorithm has been proposed by al fandi 
et al. GA operators such as mutation, cross over, and selection operator has taken time and there by 
the parameter tuned by GA is delayed. This GA operator shows that convergence was guaranteed but 
it seems like time was uncertain and the parameter updation is not straightforward. 
The optimal fuzzy PI controller based on mamdani type structure for the blood glucose in diabetic 
patient is proposed by abadi et al.It is been tested with three different parameters on three different 
patients in order to check the performance characteristics of the proposed controller.  In relative to 
the existing insulin injection rate, this proposed controller reduces the insulin injection rate and time 
margin. Thus the convergence may occur in certain forms [5]. 
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2. Modeling of blood glucose level system 
2.1. Introduction 
In this chapter, a detailed explanation of the blood glucose level system and its modeling has been 
discussed. This chapter deals with glucose monitoring system, insulin infusion system, automatic 
insulin pump and its parts are discussed. Also, the state space modeling of blood glucose level system 
is explained step by step. 
Continuous Glucose Monitoring System 
Electro enzymatic sensor which is small flexible probe that is placed just underneath the skin of 
patient which is surrounded by glucose concentration (i.e. blood),glucose oxidized by enzyme in the 
blood is present on the tip of the sensor to give hydrogen peroxide and other elements, this hydrogen 
peroxide then diffuses in the base metal layer of the sensor where it is oxidized to form hydrogen, 
oxygen and electrons which we measure as a current which is proportional to the concentration of 
glucose in the patient’s body. 
Insulin Infusion System 
This system is used nowadays by allowing patients to inject insulin rapidly rather than periodically, 
transmitted signal from  CGM is being monitored and processed by the infusion system and it is used 
to inject the insulin into patients body to maintain the level of insulin in the patients body, though 
there is a disturbance which can affect the CGM rate an approach is made by us to compensate the 
disturbance and process the system to inject precisely as required for the patient 
Automatic insulin pump  
An insulin pump is small electronic device look like a mobile phone is attached to our belt , or it can 
be placed inside pocket or even it can attached in bra so that it can hide from others. 
Those pump is injected to your body24 hours is monitor. Whenever your body reduce or increase 
glucose level it will control by injecting insulin. 
Basal rate 
Every body has a insulin rate to maintain the glucose level. according to the rate of. pancreas  will 
secrete the insulin. Due to malfunction of pancreas we programmed insulin rate made based on the 
health care professional according to your body. So that programmed insulin rate is called as basal 
rate.  
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The basal rate can be increased or decreased based on your needs. According to the basal rate the 
pump inject the insulin to your body 
Bolus dose   
Additional insulin also possible you can add according to your body you have eaten. So that you can 
correct your high blood sugar 
The insulin pump consist of 
• It has compartment and reservoir 
• Compartment only holds the reservoirs  
• Reservoir filled with the insulin 
• Infusion set connects insulin reservoir to your body  
• The infusion set is connected in our body through a tinny tube(cannal) it is placed under the skin 
• Infusion set is connected to the reservoir with the small tube so that it can be connected and dis-
connected easily 
 
 
Figure 2. Automatic insulin pump [6]. 
Three main component of the insulin pump 
• Insulin pump 
• Reservoir 
• Infusion set 
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Insulin pump  
A small durable electronic device that consists of: 
• Buttons for programming insulin navigation  
• A LCD colour screen for visual 
• Battery compartment  
• A reservoir compartment 
Reservoir  
A plastic cartridge filled with insulin is locked to the  pump. It comes with a transfer guard, the top 
piece is removed before inserting insulin pump. It can store upto300  units of insulin 
Infusion set 
It consist of thin tube  from the reservoir to the infusion site in your body. a small needle is injected 
to the canal and removed, once it is located. It goes on the same place where the insulin injections are 
given. The infusion set is replaced over a period of two or three days [6]. 
Advantages of insulin pump: 
 
 
Figure 3. Advantage in insulin pump [6]. 
The above fig.3 shows the main three advantages of the insulin pump system  
 
 
 
 
 
INSULIN 
PUMP 
MORE 
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EASIER 
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Main parts of automatic insulin pump system: 
                     
Figure 4. Main parts of insulin pump [6]. 
The above fig. 4. shows the main three part of automatic insulin pump system. 
2.2. Evolution of insulin pump technology 
Initially insulin pumps were only used for research purposes.  It was then commercialized in the year 
1970 for diabetic patients as they can calculate the amount of insulin for finding glucose reading and 
food coverage. Due to the advanced technology, the usage of pump has increased approximately up 
to 350,000 people in the U.S and also 30,000 people had type 2 diabetes. In addition advanced features 
were introduced such as self-monitoring of glucose level as they communicate wirelessly through 
infrared technology. This helps in eliminating errors which are occurred due to manual operation. For 
example: the technology of touch screens are incorporated  in T-slim insulin pump and disposing 
pumps are also used. On estimated scale, the cost of insulin is around US $6000.[7], [8], [9] 
 
Figure 5. Medtronic minimized insulin pump [10]. 
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fig. 5. A Medtronic Minimized Insulin Pump with a  blood glucose meter that communicates readings 
wirelessly [10]. 
 
 
Figure 6. T slim insulin pump [10]. 
fig. 6. The T-slim Insulin Pump is trending among the young patients, beacuse of its innovative 
touchscreen [10]. 
 
 
Figure 7. Omnipod tubeless insulin pump [10] 
 
fig. 7. The OmniPod Tubeless Insulin Pump with a pod (right) and a handheld device that functions 
as a blood glucose meter and based on patient‘s settings it communicate‘s wirelessly [10]. 
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Figure 8. Medtronic ipro2 [10]. 
 
The Medtronic iPro2 Professional Continuous Glucose Monitor (Fig.8)with its charger, and a 
Downloaded Tracing showing daily color-coded readings (Fig. 9) given below [10]. 
 
 
Figure 9. Tracing graph [10] 
 
2.3 Selection of canditate for pump use 
The diabetes can be treated by using insulin pump as they control essential needs such as self care 
and better glycemic control .These patients need to be aware of the advantages of changing into 
insulin pump and the amount of exertion required. In addition it must be clear that a pump is a 
concentrated device as programming and active communication is required. Features such as self-
checking of blood glucose level, capacity required and active communication  with the expert pump 
is essential for accomplishing the usage of pump successfully.[10] 
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Indication of insulin pump therapy 
• Imperfect glycemic control regardless of endeavors different day by day insulin infusions  
 
• Visit or erratic hypoglycemia and hypoglycemia ignorance  
 
• "Day break" wonder with persevering early-morning hyperglycemia  
 
• A dynamic way of life (exercise, strenuous physical action, athletic interests)  
 
• Kids and youthful grown-ups who normally want less limitations and greater adaptability  
 
• Development spurt of youthfulness  
 
• Bias arranging and pregnancy  
 
• Nearness of gastroparesis  
 
•     Frenzied way of life and regular travel  
 
• Move work and sporadic every day plans  
 
• Requirement for adaptability in sum and dinner schedules 
 
• type2 diabetes with expanded insulin prerequisites [10]. 
 
2.4. Types of diabetes 
Diabetes mellitus 
The metabolic disorder known as Diabetes Mellitus is the most common form of diabetes which 
results due to the deficiencies and abnormalities in insulin. The major defect in secretion of insulin 
leading to hyperglycemia happens when pancreas produce excess insulin due to the force exerted by 
the insulin resistance. Other disease such as cardio vascular, nerve damage, retinal damage, chronic 
renal failure can be triggered by long term hyperglycemia   
Hypoglycemia 
Hypoglycemia is defined as low plasma glucose concentration which occurs when blood glucose 
level reaches below 70mg/dl which indicates  symptoms  such as nervousness, shakiness and 
metabolic changes. Most common type of hypoglycemia is called post granted hypoglycemia 
occurring after the intake of food [13]. 
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Hyperglycemia  
Hyperglycemia occurs when the blood glucose level is above 270 mg/dL. This can arise when 
diabetics eat large amount of meal or the insulin in the blood is low level. It is dangerous when 
hyperglycemia is not treated [13]. 
Benefit of the automatic insulin pump system 
Diabetes: 
 Patients suffering from type1 and type2 diabetes can be benefitted. 
Hyperglycemia patients 
A person has hyperglycemia, when the blood glucose level is above 270 mg dLwithout appropriate 
treatment given to that patient hyperglycemia can be dangerous.it is predominant when diabetic 
patient eat large meal or insulin level get declined in the blood [13]. 
Hypoglycemia patients 
A person has hypoglycemia when the blood glucose level is below 60 mg dL. This can happen ex. 
Over exercise, insulin dosage high, food contain small amount of carbohydrates or if the diabetic 
skips meals. Hypoglycemia canresult in loosing ofthe conscience. when insulin used as treatment 
issue in hypoglycemia can be avoided.This Kind of patients are highly beneficial by this project, as 
it test the blood glucose level time to time and  insulinis  being injected into the patients’ blood  to 
maintainthe glucose level in the blood automatically [13]. 
Bergmann’s Minimal Model 
Bergman’s minimal model is described as the compartment including  basal concentration of  insulin. 
And glucose level in the body. It consist of two minimal models.  
Glucose kinetics describes  how the concentration  of blood glucose reacts with  blood insulin , wheras 
insulin kinetics describes how the concentration of blood insulin reacts with  blood glucose by taking 
both the data’s of insulin and glucose as input 
25 
 
Figure 10. Bergmann’s minimal model [14]. 
fig. 10. The figure elucidates tank containing  glucose fluid  by determining  closed-loop relationship 
between , insulin secretion,  glucose  and insulin action.  
The level of glucose is defined by balancing between the rate of utilization and the rate of production. 
After food intake , the glucose level increases as the   hormones  get suppressed  from the fat . Due 
to which less glucose is produced in the liver. More specifically extra pancreatic  tissues  are 
represented including the overall glucose utilization and their effects in insulin [14]. 
2.5. Modeling of blood glucose level system 
In human being body there are many feed back control loop for e.g.. We all  know that pancreas 
secrete insulin. That insulin which regulate glucose. When we consume our food that food breakdown 
by the help of digestive system and glucose will rise and it help to produce insulin. The main role of 
cell which uses insulin to breakdown the glucose. the main problem  of diabetic patient is they don’t 
have capacity to produce insulin especially the type 1 diabetic patient they don’t have capacity to 
produce insulin completely. So they have to monitor and inject several time in a day to help control 
their glucose level. A typical patient having this huge problem then they helping us a control system. 
there are few action which is free forward in nature. Like administration gives insulin shot which 
should be compensate with meal consumption and some other are feed back in nature, these patient 
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will inject insulin based on their glucose level measured those measurement seen in “finger pricks” 
and they analysis glucose. 
Long term, hyperglycemia patient can cause problem like blindness and also some cardio vascular 
problem 
Short term, hyperglycemia patient cause problem like diabetic coma or fainting. Because of this 
problem our engineers came out with more advance technology in closed loop system now present 
technology has external pump along with reservoir contain insulin in it. That will inject insulin 
continuously. This technology especially for the patient who want to inject insulin several time a day. 
With external pump still the patient has to monitor their glucose level. And In future they have plan 
to develop implantable glucose sensor and insulin pump. This sensor will measure the glucose level 
and send this to wrist watch size controller. From the controller it send signal to the insulin injection 
pump. Here closed loop as a pancreas of type 1 diabetic patient [15] [16]. 
Mathematical modeling 
Bergman minimal model is widely used model for the insulin injection and meal(glucose) input these 
are explained by three differential equation 
1/)(/
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..................................... (2.1) 
Where, 
G – blood glucose deviation  
I – insulin concentration 
X – is equivalent to the concentration of insulin within a remote area 
Input are Gmeal and U 
Gmeal – meal disturbance i/p of glucose 
U – manipulated insulin injection rate 
By using this value we can determine basal rate of infusion in insulin for maintaining a steady state 
[17]. 
 
Linearised state space model 
This model helps to develop control system design the state, i/p, o/p variable (in deviation form) 
define as, 
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From this matrix we got two input (first input, second input) 
First input = manipulated( insulin injection) 
Second input = meal glucose disturbance  [18] 
The state space model of the process is given as follows 
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C =  001    D =  00  ................................................. (2.3) 
Example set of parameter  
Imagine a diabetic patient is modelled with the help of following parameters ( lynch and 
bequette,2001) 
Gb = 4.5mmol/liter 
Ib = 4.5mU/liter 
V1 = 12 liters 
P1 = 0 min
-1 
P2 = 0.025 min
-1 
P3 = 0.000013mU/liter 
n = 5/54 min-1 
notice that concentration is in mmol/liter unit and glucose disturbance in gram unit so it should be  
simply conversion factor 5.556 mmol/g to Gmeal  
from steady state solution we came to know the basal rate should ne UB= 16.667mu/min. the below 
resulting state space model is take by using this value parameter [19] 
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 ............................... (2.4) 
It is  common  to work with glucose concentration unit “mg/deciliter” instead of “mmol/liter “since  
molecular weight of glucose = “180g/mol”. We have to multiply our obtained glucose rate 
“mmol/liter” by 18 to get the measured glucose o/p “mg/deciliter” this leads to below state-output 
relation. [19] 
C=  0018    D=  00  ......................................................... (2.5) 
The process transfer function is 
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gp(s) = -3.79/(40s+1)(10.8s+1) .................................................. (2.6) 
Because of the cancellation of pole/zero. And the following disturbance transfer function is. 
Gd(s) = 8.334/s ............................................................................ (2.7) 
A meal disturbance is best model as pulse among various chemical process disturbances, imagine that 
in 15min period 50g glucose meal is consumed, then obtain magnitude of 3.333g/min for the pulse 
during 15min period. [10] [20] 
gd(s) = 8.334/s(20s+1) ............................................................... (2.8) 
Likewise, numerous chemical process disturbance, a pulse imagine containing 50 g glucose meal is 
consumed on a 15-minute interval ;then the pulse  has a greatness of 3.333 g/minute for a length of 
15 minutes. [19][20] 
2.6. Simulation results 
The model of the blood glucose level system is developed using Matlab/Simulink as shown in fig. 
11. 
 
Figure 11.  Mathematical model of blood glucose level system 
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The open loop response of the blood glucose level system is shown in fig. 12. 
 
 
Figure 12. Open loop response of blood glucose level system 
 
 
2.7. Conclusion 
Thus the mathematical model and the linearized state space model of the process taken is presented 
in this chapter. The state space model obtained is based on the states considered and the modeling is 
the first step in designing a controller. 
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3.Design of pd and imc controller 
3.1. Introduction 
In industries each process is automated, so it is vital to maintain the varying parameters like 
flow,level,temperatue,pressure, etc. of the concerned operation at the rquired value for effective, 
economic and safe operation.  The difference between the set point and the measured controlled 
variable (i.e error) is sent to the controller. When the error arises, then according to the set point the 
controller adjusts the actuator.  Such control system are known as closed loop control system. It 
mainly  consists of  a controller, actuator and a measuring device. Either Pneumatic or Electronic 
controller can be used to perform the control action. The operation whatever, carried out by the 
pneumatic principles are preffered the most, because those system are safe. In the explosive 
environments such as refinery and industries where the application of electronics systems might cause 
dangerous issues. Pneumatic systems which uses air, are widely used. Hence , due to its safety 
consideration pneumatic signals are used mostly for operating  valves.[21] [22] 
3.2. PD controller design 
Proportional-Derivative or PD control combines proportional control action and derivative control 
action. It improves the overall transient response of the system, it could handle any operation with 
time delay and it also reduces the settling time by modifying damping and reducing the peak 
overshoot. 
PD controllers are employed for sluggish and integrating process. PD controller mode is mainly used, 
in order to predict future error. So by using this, effect of extra or additional dead time could be 
reduced. Due to the instant change in the desired value of process variable will end with a maximum 
overshoot in PI control, hence in PD control, effect of integrating action will be reduced by summing 
up the Proportional action term along with derivative action term .  
 
Figure 13.1. Feedback controller Scheme (PD) [23]. 
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Where the ‘r’ is the setpoint of the closed loop system, Gc(s) is the PD controller and Gp(s) is the 
begmern  
The equation is represented as, 
------(3.1) 
Where, 
C(s) =  PD controller’s output 
KP =  Proportional Gain 
KD=  Derivative Gain  
ep (t)= Desired Value of controlled variable – Measured Value 
P(0) = the output of controller (if error = zero) 
From the equation, we can say that this mode cannot eliminate the steady state error of proportional 
controller. However, it can handle fast process load changes as long as the load change steady state 
error is acceptable.The parameter of a PD controller is tuned using Ziegler–Nichols closed loop tuning 
method [21][22]. 
Zn method (zingler – Nicholas) uses a closed loop controller. And it require some following step 
• first step is to be bring the system in steady state condition 
• By using the p control, changing the set point and differ gain until the system oscillating 
continues. This frequency is 𝜔𝑐𝑜 and M is amplitude ratio 
• Compute following: 
Ultimate Gain = Ku = 1/M 
Ultimate Period =Pu = 2π/𝜔𝑐𝑜 
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Table.1 Ziegler–Nichols closed loop tuning method 
Ziegler–Nichols 
Kp 0.8 Ku 
Kd Pu/1.2 
 
3.3. Internal model control  
The Internal Model Control (IMC) depends upon the Internal Model Principle, which defines that 
control perfect control is theoretically possible, if exact model of the process is available. fig. 13.2. 
represent the open loop control system. 
 
Figure 13.2. Open loop control system.[23]. 
A controller, Gc (s) , is used to control the process, Gp(s) . Suppose ?̃?𝑝(𝑠)  is a model of 
Gp(s). By setting Gc(s) to be the inverse of the model of the process, 
Gc(s) = ?̃?𝑝(𝑠)
-1, -----(3.2) 
and if Gp(s) = ?̃?𝑝(𝑠)  ------(3.3) 
then it is clear that the output will always be equal to the setpoint. From this, it is concluded that 
complete knowledge about the process being controlled is well known, we can achieve perfect control 
through open loop itself. 
In practice, however, process-model mismatch is common; As the process model is not 
invertible and the unknown disturbances affects the system. To maintain the set point, the above open 
loop cannot be used.  it forms the basis for the developing  a control strategy which has the potential 
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to achieve perfect control. This  Internal Model Control (IMC) stratergy  has the general structure 
depicted in fig. 14 [23]. 
 
Figure 14. IMC general structure [27]. 
From the above diagram,  d(s) is considerd as an unknown disturbance, which affects the process of 
this system. A  input 
U(s) is given to the process and  process model ,which is known as manipulated input. Finally, the 
concerned output of the process, Y(s), and the output of the model are compared, which is results in 
a signal ?̂?(s). That is, 
?̂?(s) = [Gp(s) - ?̃?𝑝(𝑠)]U(s) + d(s) ----(3.4) 
for example, the measure of difference in behaviour between the process and process model would 
be ?̂?(s), if d(s) is equal to zero. But , if Gp(s) = ?̃?𝑝(𝑠), then obviously ?̂?(s) will be  equal to the value 
of  unknown disturbance. So ,?̂?(s) may be the information that is absent in the model, ?̃?𝑝(𝑠) , and  it 
could be used further to improve the control action. This could be  done by considering the differnce 
between ?̂?(s) and setpoint R(s), which is actually a similar  method to effecting a setpoint trim. Then, 
the final control signal is represented by, 
U (s) = [ R(s) – d(s)]Gc  (s) = { R (s) – [ Gp (s) – Gp (s)] U (s) – d(s)} Gc(s) ----(3.5) 
Thus, 
 U(s) = 
[𝑅 (𝑠)−𝑑 (𝑠) ]𝐺𝑐 (𝑠)
1+[𝐺𝑝 (𝑠)−𝐺𝑝 (𝑠)]𝐺𝑐 (𝑠)
   ------(3.6) 
 
Y(s) = GP (s)U(s) + d(s)     -----(3.7) 
 Thus,the transfer function for the IMC  is ., 
Y(s) = 
[𝑅 (𝑠)−𝑑 (𝑠) ]𝐺𝑐 (𝑠) 𝐺𝑝(𝑠)
1+[𝐺𝑝 (𝑠)−𝐺𝑝 (𝑠)]𝐺𝑐 (𝑠)
 + d (s)       -----(3.8) 
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Or, Y(s) = 
𝐺𝑒 (𝑠)𝐺𝑝 (𝑠)𝑅 (𝑠)+ [1−𝐺𝑒 (𝑠)𝐺𝑝 (𝑠)]𝑑 (𝑠)
1+[𝐺𝑝 (𝑠)−𝐺𝑝 (𝑠)]𝐺𝑒 (𝑠)
  ------(3.9) 
The  above mentioned expression of a closed loop system, states clearly, if Gc(s) = ?̃?𝑝(𝑠)
-1 and if 
Gp(s) = ?̃?𝑝(𝑠), then precise setpoint tracking of setpoint and even elimination of disturbance could be 
done, even if  theoretically Gp(s) ≠ ?̃?𝑝(𝑠) , so  disturbance elimination  could still be made perfectly  
with Gc(s) = ?̃?𝑝(𝑠)
-1. By minimising the effects of process model missmatch, robustness could be 
improved. A filter Gf(s) , which has the characteristics of low pass is made in series with inverse of 
process model Gimc(s) = Gc(s)Gf(s),which is basically the design of controller.  It is designed in order 
to reduce the effects of process missmatch, which occurs at the  high frequency end  of frequency 
reponse.  For applying  low pass filter, the order of the filter should be chosen such that Gc(s)Gf(s) is 
appropriate, to safeguard the extra differential control action. Thus, the final  closed loop then 
becomes 
Y(s) = 
𝐺𝐼𝑀𝐶 (𝑠) 𝐺𝑝 (𝑠)𝑅 (𝑠)+[1−𝐺𝐼𝑀𝐶 (𝑠)𝐺𝑝 (𝑠)]𝑑 (𝑠)
1+[𝐺𝑝 (𝑠)−𝐺𝑝 (𝑠)]𝐺𝐼𝑀𝐶 (𝑆)
  -----(3.10) 
 
IMC design procedure 
The transfer function model  is given  below: 
Gp (s) = 
−3.79
(40𝑠+1)(10.8𝑠+1)𝑠
 ............................................ (3.11) 
Internal model controller was designed 
 block diagram of IMC controller for blood glucose system is likely shown in the figure.  
The transfer function model of diabetic patients is considered (Lynch and Bequette 2001), 
The model transfer function is, 
Gp=-3.79/(40s+1)(10.8s+1) .................................................... (3.12) 
The controller parameters for PD and IMC are analytically tuned using the formulas. The obtained 
controller parameters settings are given below, 
Kp=-0.516, Kd=0.1010 ........................................................... (3.13) 
The IMC controller parameter λ is 0.15.  The closed loop simulation study was conducted to analyze 
the performance of PD and IMC controller for blood glucose system [11][12][23][24]. 
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Table.2 The Controller parameter of PD and IMC 
Controller Controller parameter 
PD Controller Kp Kd 
-0.00948 28.53 
IMC Controller 
Λ 
0.15 
 
 
Figure 15. IMC based controller for blood glucose system [24]. 
 
The level of blood glucose, has to maintain a particular level while it increases, naturally pancreas 
inject the insulin to our body to maintain the glucose level whereas for type-1 diabetic patients 
pancreas doesn’t inject the insulin so insulin pump injects the insulin The glucose sensor continuously 
monitoring the blood glucose level after a meal the glucose level is increases drastically it has refers 
to input disturbances to the process. The Process is first order with dead time process. The single loop 
PID controller is used for control the blood glucose system. Insulin pump there is a stepper motor it 
coupled with a injection needle shaft. If the glucose level increases the PID controller produces a 
control signal in terms of voltage to drive a stepper motor. The displacement of shaft is equivalent to 
injection of insulin into human body. 
 The PD controller tuned using GA to achieve minimum ISE. The PD control signal affects the insulin 
system due to its oscillatory response; the time take to regulate the blood glucose is high. To overcome 
this complexity IMC controller is used. In practice, the glucose level does not enter the blood stream 
immediately. Meals take some time to reach it into blood stream. Assume, the patient is taking 50g 
36 
meal over 15 minutes. Hence 3.3g/minutes pulse is applied in simulation for 15 minutes. The glucose 
level increases suddenly due to the meal, and it is gradually reduced by applying insulin. Figure 13 
shows the Comparison of PD response, IMC response to meal disturbance  
The simulation starts with time t=0, the setpoint for the closed loop control is set as 80 mg/deciliter , 
then meal disturbance is given to closed loop system at 400 seconds . The both controller tries to track 
the glucose in the desired level.[11][12] 
3.4. Conclusion 
Thus the closed loop controller design using PD and IMC for the blood glucose level system have 
been designed and discussed broadly in this chapter. In the next chapter, the design of controller i.e, 
PD and IMC using optimization technique has been discussed.   
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4. Design of pd and imc controller using particle swarm optimization technique 
4.1 Introduction  
This chapter describes the design of fuzzy gain organized Particle Swarm Optimization (PSO) based 
PID controller design for the control of CSTR,  with highly nonlinear characteristics. The GA and 
DE techniques involve many operations like crossover, mutation and selection making the process 
computationally tedious. An alternate method, PSO is investigated in this chapter. PSO requires 
position and velocity updation making it computationally simpler.  In the present work, a try  has 
been given to tune the PID controller parameters using the techniques of PSO.  Fuzzy gain scheduler 
is attempted for the gain selection to accommodate the entire range.[25]    
 4.2 PSO principles  
PSO algorithm is a type of optimization and a process change (evolution) computation technique. 
This  mode is really effective in the application of problem solving, multiple optima, indication of 
nonlinearity, non-differentiability and it has high measure in one direction via adaptation derived 
from the theory of social psychologic . The fundamental PSO is built from swarm techniques like, 
flocking and fish schooling. Thus, the postulate made through the observstion, it is clear that the data 
(information) sharing happens in  bird flocking. From, the observation of human groups behaviour it 
is clear that each individual has its own behaviour depends on the behaviour patterns which is 
recognised by customs and other more behaviour patterns based on the individual experience. This 
postulate is the fundamental idea of PSO. In this algorithm, when  a d-variabled optimization problem 
is considered, a group of particles are located into the d-dimensional search space with random 
positions and velocities by knowing it‘s best values, Pbest and the position in the   d-dimensional 
space. By self the flying experience of other particle, velocity of each particle could be altered. Thus 
,The ith particle is presented as ϰi =(ϰi1, ϰi2,…..,ϰid) in the d dimensional space.  The  previous best 
positions of the ith particle is coded  again and presented as  
 Pbesti  = (Pbesti1 ,Pbesti2,….., Pbestid) ...........................................................................         (4.1)  
 Best particle which outstands among all of the particle is gbestd.  The velocity of particle i is 
presented as ʋi = (ʋi1, ʋi2,….., ʋid).   
 By applying  the current velocity and distance from Pbesti d to gbesti d. The position and modified 
velocity of the particles could be determined, which is presented in the following formulae  ʋi,m(t+1) 
=  w.ʋi,m(t) +c1* rand( )*  (pbesti,m  - ϰi,m(t))     +c2* rand( )*  (gbesti,m  - ϰi,m(t)).......        (4.2)  
ϰi,m(t+1) = ϰi,m(t)+ ʋi,m(t+1)..........            (4.3)  
 where   
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 i  = 1,2,….,n  
 m = 1,2,….,d  
where  
 t    - Number of iteration  
 n    - Number of particles in  group  91 
 d    - Dimension  
 i   - Pointer of iterations (generations)  
 m    - Population  ʋi,m(t+1) -  particle I velocity at iteration (t+1)  ʋi,m(t) -  particle I velocity at 
iteration (t)     Vdmin ≤ ʋi,d(t) ≤ Vdmax  
 w   - Inertia weight factor  
 c1,c2   - Acceleration constant  
 rand( )   - Random number from 0 to 1  ϰi,m(t)  - particle I  curent position at iteration (t)  ϰi,m(t+1)  
- particle I current position at iterations (t+1)  pbesti m  -  previous best, position of the ith particle  
 gbesti m  - Best particle in the population.[25] 
4.3  pso based pd tuning and minimizing the performance index  
 fig. 16 shows the flowchart of PSO based Tuning of PD  control.  PSO based design of controller 
gives a try to reduce the error that occurs in the system due to some inputs, system error could be the 
difference between the desired and the actual response of a particular system. The measure of system 
error depends on performance criteria. The method of  PD controller design minimizing IAE, ISE and 
ITAE using PSO are proposed.  The  Swarm Optimizations techniques is used for auto tunning PD 
controller. In this techniquethe tuning of  PD parameters are done by using PSO techniques. The same 
is used in online for  minimum performance index  and for each region individually. 
 
 
.  
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Figure 16. Flowchart of PSO based tuning of Pdcontrol [25]. 
start 
Generate intial population 
Simulate closed loop control system 
for each set of controller parameter 
Calculate performance index (F) 
Calculate Fitness function = 1/F 
Calculate pbest of each particle and 
gbest of population 
Update velocity, position ,gbest and 
pbest of particles 
Maximum 
interaction 
number 
reached? 
END 
40 
 For PSO, PID parameters are the particles  fig. 17 represents the block diagramfor PSO based tunning 
of PID parameters using PSO minimizing  IAE.  Initially, the position of particles are initialized 
randomly. Then, by using the fitness function which is based on the error inverse form, gbest and  
pbest are found. Fitness function is denoted as 1/IAE. A better performance could be achieved in 
system‘s response by making larger value of the fitness function.  Computation of  particle‘s next 
movement coud be done,by updating the position and velocity vectors.  Fitness functions of the 
optimized PID parmeters with larger values are decided by repeating required number of 
iterations.The number of iterations carried for the simulation of process is 30 with an inertia of 1. The 
correction factor c1 , the cognitive acceleration is considered as 2.0 and c2  the social acceleration is 
considered as 3.0 with 25 of swarm size for  lower region. The correction factor c1 is chosen as 2.0 
and c2 as 20.0 with a swarm size of 40 for the middle region. The correction factor c1 is taken as 2.0 
and c2  as 2.0 with 20 of swarm size for higher region. Trail and error methods are used to select the 
accleration factors. For  the three different operating regions, simlation results are reported.[25] [11] 
[12]. 
 
 
Fig 17. Closed loop block diagram for online tuning of PD [25]. 
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Table.3 The Controller parameter obtained by PSO algorithm 
Controller Controller parameter 
PSO-PD Controller Kp Kd 
-0.01459 -0.5102 
PSO-IMC Controller 
Λ 
0.1041 
 
4.4. Simulation study 
The closed loop response of CSTR is studied separately in each linear region with the optimized PID 
controllers.   It is evident that the output response follows the set point without overshoot or 
undershoots.  Even in unstable region the set  point is tracked with zero steady state error using the 
optimum controller  parameters with some oscillations in the initial response 
4.4.1. PSO Based PD Controller  
 
 
figure 18. Matlab/simulink model of the PSO based PD controller for blood glucose level 
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Figure 19. Closed loop response of PSO based PD controller in the blood glucose level control 
 
fig. 19. shows the servo and regulatory response of the BLC.  Initially the set point is fixed as 5 
kgmol/m3 and at 100th sampling instant the feed concentration is changed by 5%.  At 200th sampling 
instant, the set point is set to 1 kgmol/m3 and at 300th sampling instant 5% change is given to the 
feed temperature and at 400th sampling instant the set point is given as 8 kgmol/m3 and the feed 
concentration is varied at 500th sampling instant.  The  response reveals that the controller scheme 
provides good tracking and  regulatory control of the BLC. 
 
4.4.2 PSO Based IMC Controller  
 
 
Figure 20.Matlab/simulink model of the PSO based IMC  for blood glucose level 
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Figure 21. Closed loop response of PSO based PD controller in the blood glucose level control 
 
fig. 21. shows the colosed loop Pso Based PD controller response. Simulation results are reported for 
the Servo tracking of PSO based PD and PSO based IMC controller.   
Performance index 
A measure know as performance indices. Performance index are shown below in three express 
error signal. 
1. Integral square error (ISE) 
ISE = ∫ ⅇ2 (𝑡)  𝑑𝑡
∞
0
 
2. Integral absolute error (IAE) 
IAE = ∫ |ⅇ (𝑡)|  𝑑𝑡
∞
0
 
3. Integral time absolute error (ITAE) 
IATE = ∫ 𝑡|ⅇ (𝑡)|  𝑑𝑡
∞
0
 
 
 
Table.4 Comparison of performance measures of servo and regulatory   response of controllers 
Controller IAE ISE ITAE 
PSO-PD 1176 2066 1.219*104 
PSO-IMC 865 921 0.2947*104 
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The performance indices for the PSO based PD and PSO based IMC minimizing IAE, ISE and ITAE 
are tabulated in Table. 4.  The IAE and ISE criteria results in a response with  small overshoot and 
weighs, where  all the errors are equally independent of time. The ITAE does not discourage  against 
initial error which is large in the response following the step demand, but  penalize errors which are 
smaller at a time later. 
 4.5. Conclusion   
In this chapter, PSO based PD and PSO based IMC controller minimizing the performance indices 
are applied for the control of Blood Glucose Level process.  PSO based IMC concentrates on the 
minimization of the performance indices,  IAE, ISE and ITAE.  The PSO based IMC techniques have 
been proven to be more efficient in controlling the blood Glucose level with faster settling time and 
minimum integral value.  
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5. RESULTS AND DISCUSSION 
5.1. Introduction  
To achieve the controller performance goals by designing the different controllers to control the blood 
glucose level system and their response are compared  effectively with the common controller. The 
PD and IMC controller schemes are used in the research work to control the level of blood glucose. 
The PD and IMC controller are tuned using the conventional rules and trial & error method. The PSO 
algorithm is applied to obtain the parameter of controller for minimum value of integral square error. 
The research work is carried out to check the capability of controller in the regulating the blood 
glucose level of human body. The BMM is considered as human body for implementing the 
controllers in the simulation environment.  
5.2. Performance Analysis of PD controller 
The PD controller performance for the control of blood glucose level is investigated for the desired 
setpoint of glucose level 140mg/dL.  In order to evaluate the regulatory performance of the PD 
controller, the meal disturbance is applied as a pulse at 400 sec as shown in figure. 22 The PD 
controller trying to regulate the meal disturbance as well as to maintain the desired glucose level 
140mg/dL.  
figure. 23 show the closed loop simulation response of PD controller. It can been seen from the figure. 
23 is that the controller rejects the meal disturbance faster, but there are huge overshoot with 
oscillation in the control of glucose level. It is found that PD controller provides large settling time 
with larger integral indices.  
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Figure 22.  The input meal disturbance signal 
 
Figure 23. Closed loop response of PD controller in the blood glucose level control 
5.3 Performance Analysis of IMC controller 
The PD controller performance for the  blood glucose level control is investigated for the desired 
setpoint of glucose level 140mg/dL.  For  evaluating the regulatory performance action of the IMC 
controller, the meal disturbance is applied as a pulse at 400th minute with 3.3g as shown in figure. 24 
There is lack of analytical rules in the literature for the tuning the filter time constant in the  IMC 
controller . Hence, The IMC controller parameter was fixed trial and error. The IMC controller 
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regulate the meal disturbance as well as to maintain the desired glucose level 140mg/dL faster than 
the PD controller.  
fig. 25. show the closed loop simulation response of IMC controller. It can be seen from the fig .26. 
is that the controller rejects the meal disturbance faster than PD controller. It is found that IMC 
controller provides large settling time with larger integral indices.  
 
Figure 24. The input meal disturbance signal 
 
 
Figure 25.  Closed loop response of imc controller in the blood glucose level control 
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Figure 26. Comparision of PD and IMC control response 
 
5.4 Performance analysis of PSO based PD and PSO-IMC controller.  
The researchers started applying the optimization algorithm in the design of controller tuning. As 
discussed in the chapter 4, the PD and IMC controllers are tuned using PSO for minimum values of 
ISE. The simulation study is carried to compare the performance of proposed controller. The 
following simulation results show that the desired objectives of achieving minimum ISE are achieved. 
The simulation started with time t=0 , without any disturbance. The controller tracking the set point 
of 120 mg/decilitre level and then the meal disturbance with magnitude of 3.33g/minute is applied at 
400th minute as a pulse which raises the glucose level of patient. The PSO-IMC based controller 
rejects the meal disturbance effectively than PSO-PD control. The PSO-IMC regulates the glucose 
level within 40 minutes after having meal whereas PSO-PD takes longer time to regulate the glucose 
level. 
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Figure 27. the input meal disturbance signal 
  
Figure 28.  closed loop response of pso-pd and pso-imc controller in the blood glucose level control 
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Figure 29.  Matlab/simulink model of all the control schemes 
 
 
Figure 30.  The input meal disturbance signal 
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Figure 31. closed loop response of PD, IMC, PSO-PD, PSO-IMC controller in the blood glucose level 
control 
 
The quantitative comparison of closed loop performance  action of the controllers based on 
performance indices are listed in Table. 5. 
 
Table.5 Comparison of performance measures of servo and regulatory   response of controllers 
Controller IAE ISE ITAE 
PD 1130 2867 1.154*104 
IMC 972 1253 0.998*104 
PSO-PD 1176 2066 1.219*104 
PSO-IMC 865 921 0.2947*104 
 
Comparison of responses on this basis of error indices values reveals that the performance action of 
the proposed PSO-IMC controller shows good performance.  The PD controller is tuned by PSO 
algorithm to overcome drawbacks of conventional PD controller and its performance is examined. 
The quantitative comparison of closed loop performance action of the controllers based on 
performance indices are listed in Table 5. From the table, the absolute error of PSO-IMC is 865 less 
than PSO-PD, PD, IMC controller and the integral squared error is also 921 which is lesser than other 
controllers. Comparison of responses on this basis of error indices values reveals that the performance 
action of the proposed PSO-IMC controller shows better performance. 
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5.5 Conclusion  
The project work focus on the design of closed loop controller for diabetic typ 1 patients. The injection 
which contains insulin is altered to keep the glucose level of blood in normal range at each time, by 
acquiring the difference between blood glucose level measured and  reference level . Based on the 
optimal value of glucose, the presented PSO- IMC control system regulates the glucose levels by 
injecting the insulin effectively than PD, IMC, PSO based PD control system. 
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Conclusions 
This thesis proposed control strategies for the closed loop artificial pancreas and used three diabetic 
patient models for simulation that is designed to reduce the risks of hyperglycemia. 
• In this work, the conventional PD and IMC controller are designed to investigate the 
performance characteristics of controller in the blood glucose level control. The proposed 
control algorithm is implemented for the Bergmann Minimal Model (BMM) as the diabetic 
patient model. The control algorithm is proposed to develop a closed loop artificial 
pancreas. 
• Then, the optimization algorithm is applied to in this work to optimally tune the PD and 
IMC controller. The simulation results are analyzed and reported. It is inferred that the PSO 
based IMC controller control the glucose level in the desired setpoint by applying the 
optimal insulin to patient to regulate the meal disturbance faster. The settling time of IMC 
based PD is 218.6 sec which lesser than the IMC (271 sec) , PD (310.7 sec) and PSO based 
PD (297.4 sec). 
• The optimally tuned IMC controller using PSO algorithm has yielded much better results 
than the PSO based PD, IMC and PD controller.  This work focus on the development of 
control algorithm to control the blood glucose level of patient. The PSO based IMC 
controller provides closed loop control response with minimum values of IAE as 865 , ISE 
as 921 and  ITAE as 2947 comapred to PSO based PD, IMC and PD.  
• The closed loop simulations are carried out for all the control algorithm. The PSO-IMC 
controller provides improved performance such as faster meal disturbance rejection, faster 
settling time. 
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